Lymepak | Doxycycline Hyclate Tablet while Breastfeeding
Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Lymepak | Doxycycline Hyclate Tablet.

What is Lymepak | Doxycycline Hyclate Tablet used for?


LYMEPAK is indicated for the treatment of early Lyme disease (as evidenced by erythema migrans) due to Borrelia burgdorferi in adults and pediatric patients 8 years of age and older weighing 45 kg and above. To reduce the development of drug-resistant bacteria and maintain the effectiveness of LYMEPAK and other antibacterial drugs, LYMEPAK should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. LYMEPAK is a tetracycline class drug indicated for the treatment of early Lyme disease (as evidenced by erythema migrans) due to Borrelia burgdorferi in adults and pediatric patients 8 years of age and older weighing 45 kg and above. (1) To reduce the development of drug-resistant bacteria and maintain the effectiveness of LYMEPAK and other antibacterial drugs, LYMEPAK should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria (1).

Lymepak | Doxycycline Hyclate Tablet while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Lymepak | Doxycycline Hyclate Tablet low risk for breastfeeding
Lymepak | Doxycycline Hyclate Tablet contains only one active ingredient that is Doxycycline anhydrous. We have analyzed the usage of Doxycycline anhydrous in breastfeeding and our analysis suggest that Doxycycline anhydrous poses Low risk for infant while breastfeeding and hence Lymepak | Doxycycline Hyclate Tablet itself shall be considered Low risk item for breastfeeding.

Lymepak | Doxycycline Hyclate Tablet Breastfeeding Analsys


Doxycycline anhydrous while Breastfeeding

Low Risk

CAS Number: 564-25-0

Excreted into breast milk in quantities that would be clinically significant, however, intestinal absorption by infant's gut is hampered because of formation of chelating products by union with the milk's calcium. Tetracycline is at lesser amount excreted into breast milk and at higher proportion bound to calcium, hence, it is fewer absorbed than Doxycycline. Thus, it is a optimal alternative while breastfeeding. Long-term treatments are not recommended (over 3-4 weeks) since it may cause damage of the growth cartilage, teeth discoloration and imbalance of intestinal flora. Be aware of false negative results that may be obtained from infants with bacterial cultures when the mother is on antibiotics.


Lymepak | Doxycycline Hyclate Tablet Breastfeeding Analsys - 2


Doxycycline anhydrous while Breastfeeding

CAS Number: 564-25-0

A number of reviews have stated that tetracyclines are contraindicated during breastfeeding because of possible staining of infants' dental enamel or bone deposition of tetracyclines. However, a close examination of available literature indicates that there is not likely to be harm in short-term use of doxycycline during lactation because milk levels are low and absorption by the infant is inhibited by the calcium in breastmilk. Short-term use of doxycycline is acceptable in nursing mothers. As a theoretical precaution, avoid prolonged or repeat courses during nursing. Monitor the infant for rash and for possible effects on the gastrointestinal flora, such as diarrhea or candidiasis (thrush, diaper rash).


Is Lymepak | Doxycycline Hyclate Tablet safe while breastfeeding

I already used Lymepak | Doxycycline Hyclate Tablet and meanwhile I breastfed my baby should I be concerned?

Lymepak | Doxycycline Hyclate Tablet is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Lymepak | Doxycycline Hyclate Tablet so you should inform him based on your convenience.


I am nursing mother and my doctor has suggested me to use Lymepak | Doxycycline Hyclate Tablet, is it safe?

Lymepak | Doxycycline Hyclate Tablet comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.


If I am using Lymepak | Doxycycline Hyclate Tablet, will my baby need extra monitoring?

Not much monitoring required while using Lymepak | Doxycycline Hyclate Tablet


Who can I talk to if I have questions about usage of Lymepak | Doxycycline Hyclate Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week